Evidence map›Paper›PMID 1533390›Full record

ArticleImmunology1992

Trypanosoma cruzi suppresses the expression of the p75 chain of interleukin-2 receptors on the surface of activated helper and cytotoxic human lymphocytes.

F Kierszenbaum, M B Sztein

Open access · greenAbstract read
In one paragraph

Article in Immunology, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

F KierszenbaumDepartment of Microbiology and Public Health, Michigan State University, East Lansing 48824.
M B Sztein
Michigan State University · US

Funding

LYMPHOCYTE MODULATION BY TRYPANOSOMA CRUZIR01AI026542 · NIAID · MICHIGAN STATE UNIVERSITY · PI KIERSZENBAUM, FELIPE · 1989 to 1991
–
NIAID NIH HHS AI-26542
6 · The paper itself

Abstract

When Trypanosoma cruzi is co-cultured with activated human lymphocytes the latter manifest a marked level of suppression in their capacity to express high-affinity interleukin-2 receptors (IL-2R). In this study we asked whether this effect could result from reduced expression of the p75 component of the IL-2R, a condition which would limit the number of heterodimeric receptors that could be assembled by activated T cells. The results of two-colour flow cytometric analyses revealed that both the percentage and surface density of p75 molecules on phytohaemagglutinin-stimulated CD3+, CD4+ or CD8+ lymphocytes were significantly reduced in the presence of T. cruzi, whether or not the parasites were separated from the lymphocytes by a cell-impermeable filter. These results suggested that reduced expression of p75 chains would limit the number of IL-2R assembled by activated T lymphocytes, contributing in this manner to the immunosuppression that occurs during acute T. cruzi infection.

Indexed as

Antigens, CDChagas DiseaseHumansImmune ToleranceLymphocyte ActivationReceptors, Interleukin-2T-Lymphocytes, CytotoxicT-Lymphocytes, Helper-InducerAntigens, CDReceptors, Interleukin-2

Identifiers

PMID1533390
PMCPMC1384753
OpenAlexW2417970933

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.